{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T02:56:39Z","timestamp":1648608999767},"reference-count":19,"publisher":"Baishideng Publishing Group Inc.","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2004]]},"DOI":"10.3748\/wjg.v10.i9.1372","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T06:02:34Z","timestamp":1509343354000},"page":"1372","source":"Crossref","is-referenced-by-count":2,"title":["Catheterization-associated complications of intraperitoneal chemotherapy in advanced gastric cancer"],"prefix":"10.3748","volume":"10","author":[{"given":"Meng","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Ming","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"Earle CC, Maroun J, Zuraw L. Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline. Can J Surg 2002;45:438-446."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Hu JK, Chen ZX, Zhou ZG, Zhang B, Tian J, Chen JP, Wang L, Wang CH, Chen HY, Li YP. Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials. World J Gastroenterol 2002;8:1023-1028.","DOI":"10.3748\/wjg.v8.i6.1023"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Jeung HC, Rha SY, Jang WI, Noh SH, Chung HC. Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy. Br J Surg 2002;89:460-466.","DOI":"10.1046\/j.0007-1323.2001.02048.x"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Yagi Y, Seshimo A, Kameoka S. Prognostic factors in stage IV gastric cancer: univariate and multivariate analyses. Gastric Cancer 2000;3:71-80.","DOI":"10.1007\/PL00011699"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Fu QG, Meng FD, Shen XD, Guo RX. Efficacy of intraperitoneal thermochemotherapy and immunotherapy in intraperitoneal recurrence after gastrointestinal cancer resection. World J Gastroenterol 2002;8:1019-1022.","DOI":"10.3748\/wjg.v8.i6.1019"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Witkamp AJ, de Bree E, Van Goethem R, Zoetmulder FA. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev 2001;27:365-374.","DOI":"10.1053\/ctrv.2001.0232"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Averbach AM, Jacquet P. Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer. Br J Surg 1996;83:726-733.","DOI":"10.1002\/bjs.1800830605"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Noh SH, Yoo CH, Chung HC, Roh JK, Shin DW, Min JS. Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer. Oncology 2001;60:24-30.","DOI":"10.1159\/000055292"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Maehara Y, Baba H, Sugimachi K. Adjuvant chemotherapy for gastric cancer: a comprehensive review. Gastric Cancer 2001;4:175-184.","DOI":"10.1007\/s10120-001-8008-6"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Tsujitani S, Fukuda K, Saito H, Kondo A, Ikeguchi M, Maeta M, Kaibara N. The administration of hypotonic intraperitoneal cisplatin during operation as a treatment for the peritoneal dissemination of gastric cancer. Surgery 2002;131:S98-104.","DOI":"10.1067\/msy.2002.119359"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Yu W, Whang I, Chung HY, Averbach A, Sugarbaker PH. Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J Surg 2001;25:985-990.","DOI":"10.1007\/s00268-001-0067-7"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ceelen WP, Hesse U, de Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 2000;87:1006-1015.","DOI":"10.1046\/j.1365-2168.2000.01538.x"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 1999;85:529-534.","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<529::AID-CNCR3>3.0.CO;2-9"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Sugarbaker PH. Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy. Cancer Treat Res 1996;81:149-168.","DOI":"10.1007\/978-1-4613-1245-1_13"},{"key":"ref15","unstructured":"Yu W, Whang I, Averbach A, Chang D, Sugarbaker PH. Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gastric cancer. Am Surg 1998;64:1104-1108."},{"key":"ref16","unstructured":"Esquivel J, Vidal-Jove J, Steves MA, Sugarbaker PH. Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. Surgery 1993;113:631-636."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Topuz E, Basaran M, Saip P, Aydiner A, Argon A, Sakar B, Tas F, Uygun K, Bugra D, Aykan NF. Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study. Am J Clin Oncol 2002;25:619-624.","DOI":"10.1097\/00000421-200212000-00019"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Sakuragi N, Nakajima A, Nomura E, Noro N, Yamada H, Yamamoto R, Fujimoto S. Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma. Gynecol Oncol 2000;79:420-423.","DOI":"10.1006\/gyno.2000.5979"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 1998;14:254-261.","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<254::AID-SSU10>3.0.CO;2-U"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v10\/i9\/1372.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T09:24:09Z","timestamp":1570267449000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v10\/i9\/1372.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v10.i9.1372","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2004]]}}}